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ABSTRACT 
Machado-Joseph disease, or spinocerebellar ataxia type 3(MJD/SCA3), is the most 
frequent late onset spinocerebellar ataxia and results from a CAG repeat expansion in 
the ataxin-3 gene. Previous studies have found correlation between atrophy of cerebellum 
and brainstem with age and CAG repeats, although no such correlation has been found 
with disease duration and clinical manifestations. In this study we test the hypothesis that 
atrophy of cerebellum and brainstem in MJD/SCA3 is related to clinical severity, disease 
duration and CAG repeat length as well as to other variables such as age and ICARS 
(International Cooperative Ataxia Rating Scale). Whole brain high resolution MRI and 
volumetric measurement with cranial volume normalization were obtained from 15 MJD/
SCA3 patients and 15 normal, age and sex-matched controls. We applied ICARS and 
compared the score with volumes and CAG number, disease duration and age. We found 
significant correlation of both brain stem and cerebellar atrophy with CAG repeat length, 
age, disease duration and degree of disability. The Spearman rank correlation was stronger 
with volumetric reduction of the cerebellum than with brain stem. Our data allow us to 
conclude that volumetric analysis might reveal progressive degeneration after disease 
onset, which in turn is linked to both age and number of CAG repeat expansions in SCA 3.
Key words: CAG expansion, Machado-Joseph disease, MJD/SCA3, spinocerebellar ataxia, 
volumetry. 
Análise volumétrica de cerebelo e tronco cerebral de pacientes com doença de 
Machado Joseph
RESUMO
Doença de Machado-Joseph, ou ataxia espinocerebelar tipo 3 (MJD/SCA3) é ataxia 
espinocerebelar de início tardio mais frequente e resulta de uma expansão da repetição 
CAG no gene da ataxina-3. Estudos precedentes encontraram correlação entre a atrofia 
do cerebelo e do tronco cerebral com a idade e número de expansões CAG. Tais 
correlações não foram encontradas em relação ao tempo de doença ou manifestações 
clínicas. Neste estudo testamos a hipótese de que a atrofia do cerebelo e do tronco 
encefálico em MJD/SCA3 está relacionada à gravidade clínica, duração da doença e 
número de repetições CAG, bem como com outras variáveis como a idade e a ICARS 
(escala cooperativa internacional de avaliação de ataxias). Foram realizados estudos de 
imagem pela ressonância magnética de alta resolução e volumetria com normalização 
de volume craniano de 15 pacientes portadores de MJD/SCA3 e 15 controles pareados 
por idade e sexo. Nós aplicamos a ICARS e correlacionamos com o escore de volumes e 
número de CAG, duração da doença e idade. Encontramos correlação significativa entre 
atrofia de tronco cerebral e cerebelo com duração da doença, repetição CAG, idade e 
grau de acometimento da doença. O índice de correlação de Spearman foi maior em 
relação à atrofia de cerebelo do que à atrofia de tronco. Nossos dados permitem concluir 
que a análise volumétrica pode revelar degeneração progressiva após o início da doença 
que, por sua vez, está ligada à idade e número de expansões CAG em SCA 3.
Palavras-chave: expansão CAG, doença de Machado-Joseph, MJD/SCA3, ataxia espino 
cerebelar, volumetria. 
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The autosomal dominant spinocerebellar ataxias 
(SCA) constitute a large and heterogeneous group of 
late-onset diseases. To date, at least 29 of them have been 
mapped, and 15 genes have been identified. An exonic 
unstable CAG repeat expansion is the most frequent mu-
tation associated with this group of neurodegenerative 
disorders1. 
Machado Joseph disease (MJD) or spinocerebellar 
ataxia type 3 (MJD/SCA3) seems to be the most common 
late-onset spinocerebellar ataxia in many world regions, 
including Germany, Brazil, Portugal, India, France, 
North America, Japan, China and Taiwan1-5. In normal 
individuals, the gene contains between 12 and 44 CAG 
repeats, whereas most patients have between 61 to 87 
CAG repeats6. 
This disease has been consistently associated to the 
presence of cerebellar atrophy that was initially indirectly 
demonstrated by pneumoencephalography7. More re-
cently, qualitative and quantitative magnetic resonance 
image (MRI) techniques provide a morphologic evalu-
ation of the brain structures involved in this and other 
central nervous system diseases (CNS), allowing to study 
the progression of the abnormalities and possible corre-
lations between gene defects, morphological changes and 
clinical phenotypes, leading to a better understanding of 
these diseases and their natural history8,9. 
Since the identification of the Ataxin 3 gene, several 
of such studies have been undertaken in MJD/SCA3. 
Some authors found a moderate olivary and cerebellar 
atrophy10, while others reported that cerebellar and brain 
stem atrophy are significantly more severe in SCA1 and 
SCA2, proposing that SCA2 and MJD/SCA3 could be 
distinguished by studying the velocity of the saccadic oc-
ular movement and the diameter of the middle cerebellar 
peduncle11. Some authors reported that atrophy was age 
and disease-duration dependent, affecting moderately 
the cerebellum and more severely the brainstem, spe-
cially the pontine tegmentum12. These findings were not 
confirmed by others that found correlation with age at 
examination and CAG repeats but not with disease dura-
tion and clinical severity8. This divergence increased with 
another study, which failed to find correlation between 
CAG expansion and atrophy in a series of SCA1, SCA2 
and SCA3 patients13. Cerebellar and pontine volume 
seems to be more involved in SCA7 than in MJD/SCA3 
and SCA6, regardless of severity of symptoms or dura-
tion of the disease14.
More recently, the interest have focused on pons and 
basal ganglia involvement. Interestingly, a study showed 
that the atrophic process is not uniform inside the pons, 
being the tegmentum more affected than the pontine 
base9. 
In this study we tried to sort out the correlations be-
tween image findings with clinical and genetic data ap-
plying volumetric MRI measurements of posterior fossa 
structures, aiming to more precisely define the link be-
tween morphology and function in MJD/SCA3.
METHOD 
Subjects
Fifteen consecutive patients with molecularly proven 
MJD/SCA3, and fifteen healthy normal controls matched 
for gender and age, were studied after excluding those 
with history of alcohol abuse and any other systemic or 
neurological disease. Disease duration was measured as 
years elapsed since the first motor symptom, and dis-
ease severity was measured with the International Co-
operative Ataxia Rating Scale (ICARS)15. This study was 
approved by the Research Ethics Committee of our in-
stitution, and all patients signed an informed consent. 
Molecular analysis
Lymphocyte DNA was isolated according to routine 
technique. The MJD/SCA3 gene was amplified using 
PCR as described before6. PCR product was submitted 
to 4% polyacrylamide gel electrophoresis in an automatic 
gene sequencer (ABI PRISM 377 DNA SEQUENCER-
USA). Peak product was analyzed in relation to base 
pair number. CAG expansion number was calculated 
according to the formula: (number of base pairs- 160)/3.
Image acquisition and processing
MRI was performed on a 1.5-T system (Magneton Vi-
sion, Siemens, Erlanger, Germany). The study protocol 
included a fast-spin echo axial, double echo PD-T2-
weighted and axial FLAIR sequence to screen for focal 
lesions, and T1-weighted, three-dimensional spoiled 
gradient-recalled acquisition sequence with 1 mm slice-
thickness for volumetric measurements.
Segmentation and normalization
A trained operator (STC) blinded about the clinical 
data delineated the region-of-interest (ROI) manually 
based on axial, coronal and sagittal images, according to 
anatomic landmarks already described16 (Figure). Volu-
metry was performed based on the whole brain gradient 
echo 3D, with 1 mm3 isotropic voxel, using the Display 
software package (Brain Image Center, Montreal Neuro-
logical Institute, McGill University). A semi-automatic 
algorithm with threshold of signal intensity was used to 
detect the interface between CSF, gray and white matter, 
in order to minimize the partial volume artifact. Volumes 
were obtained by voxel quantification of the brain stem 
and cerebellum. The former was divided into midbrain, 
pons and medulla oblongata, while the latter was divided 
into vermis regions (V1, V2 e V3), tonsils and hemi-
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Figure. The segmentation of the posterior fossa structures were done according the color labels showed in [B] (sagittal), [C] (axial), and 
[D] (coronal) images, after brain stem division according the boundaries showed in [A].
spheres. We used intracranial volume (ICV) including 
brain and cerebrospinal fluid for normalization of volu-
metric data, as previously published17. The operator was 
blind in relation to the identity of control and patients. 
Statistical analysis
Group comparisons were performed with the Mann 
Whitney U test allowing a confidence interval of at least 
95%. Correlation of clinical findings and volumes were 
analyzed using Spearman’s bi-variate correlation. The 
software package SPSS for Windows (SPSS Inc., Ilinois; 
version 8.0) was used.
RESULTS 
Patients age ranged from 18 to 72 years old (mean 
44.3±15.6), and the the male: female ratio was 8:7. Dis-
ease duration ranged from 1 to 21 years (mean 8.7±5.81) 
and CAG number from 65 to 88 repeats (72.7±5.3). 
Except for tonsils, all measured structures were sig-
nificantly reduced in patients than in controls (Table 1). 
Correcting the acquired values for the total intracra-
nial volume did not change significantly the findings. 
The total brain stem reduction observed in the patient 
group was 28.5%, and the most affected brain stem 
structure was pons, with an average volume reduction 
of 35.7%. The total cerebellum volume reduction was 
18.7%, mainly due to vermis (32.2%) and hemispheres 
(22.5 and 14.7%). 
As shown in Table 2, an inverse correlation of disease 
duration were found with cerebellar hemispheres (–0.7, 
–0.56; p>0.05), total cerebellum (–0.7; p<0.05), V2 (–0.69 
p<0.05) and mesencephalon volumes (–0.52; p>0.05). 
Another inverse correlation was found with CAG re-
peat number and total vermis (–0.7, p>0.05), V1 (–0.69, 
p>0.05) and mesencephalon volumes (–0.53, p>0.05). 
With the exception of tonsils, age was inversely corre-
lated with all cerebellar structures. ICARS had an inverse 
correlation with the volumes of pons (–0.68, p>0.05), 
total brain stem (–0.62, p>0.05), V2 (–0.52, p>0.05), 
cerebellar hemispheres (–0.63; –0.49, p>0.05) and total 
cerebellum (–0.6, p>0.05). In addition, ICARS and dis-
ease duration showed a direct correlation. No correla-
tions were found between studied parameters and me-
dulla oblongata and tonsil. 
DISCUSSION
In this study, we tried to correlate a volumetric anal-
ysis based on MRI examination with clinical and genetic 
data, to better understand the natural history and the 
anatomic basis of MJD/SCA3 disease. The volumetric 
Table 1. Brain stem and cerebellum volumes after normalization.
Structure Control (Mean±SD) Patient (Mean±SD) Variation (%) p
Mesencephalon 3.765 ±0.386 3.364±0.437 10.6 <0.05
Pons 13.408±2.007 8.614 ±1.935 35.7 <0.01
Medulla oblongata 2.618±0.896 2.105±0.304 19.6 <0.05
Total brain stem 19.792±2.672 14.152±2.355 28.5 <0.01
Tonsil 2.471±0.772 2.512±0.856 – >0.05
V1 1.515±0.302 0.969±0.2009 35.7 <0.01
V2 0.878±0.108 0.554±0.171 36.9 <0.01
V3 1.130±0.181 0.867±0.205 23.8 <0.05
Total vermis 3.525±0.544 2.391±0.509 32.2 <0.01
L-hemisphere 33.080±2.861 25.635±4.1025 22.5 <0.05
R-hemisphere 30.599±8.640 26.105±4.610 14.7 <0.05
Total cerebellum 69.677±10.012 56.644±9.602 18.7 <0.05
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method applied in the present study has some advan-
tages due to the use of high resolution whole brain im-
ages, a robust algorithm for partial volume reduction, 
and normalization with ICV to avoid body volume and 
technical influence. These particularities may explain 
some of the differences we found17. In agreement to our 
data, reduced brainstem and cerebellar volume in MJD/
SCA3 patients has been widely demonstrated9-13. The 
most affected brain stem structure was the pons, with 
an average volume reduction of 35.7%. This finding con-
trast with previous findings reporting only a mild pon-
tine atrophy13,14. It is noteworthy that our measurements 
included part of the cerebellar peduncles and not only 
the ventral pons, since it is impossible to define the cer-
ebellar anterior limit and brain stem anatomically. It has 
already been demonstrated that the volumes of the pe-
duncles are decreased in the disease and that there is a 
positive correlation between the width of the cerebellar 
peduncle and the diameter of the pons12. 
The most affected vermis subdivisions were V1 and 
V2 (with an average reduction of 37%) whereas V3 was 
relatively spared with an average reduction of 24%. Cer-
ebellar hemispheres evidenced an average reduction of 
19%. Subdivisions of the vermis have not been studied 
previously; neither correlations between them and other 
parameters such as age, CAG number, disease duration 
and ICARS. According to our data, the disease process 
did not affect tonsils. Given tonsils are structures which 
prove difficult to limit, having partial volume effect; we 
used some of the strategies previously described - sag-
ittal slices in parallel with coronal slices - to increase the 
accuracy of the measurements18.
Disease duration 
We found an inverse correlation between disease 
duration and midbrain, V2, hemispheres and total cere-
bellum, but not with pons. This could be a time-related 
effect on the structures derived from midbrain, cere-
bellum and anterior vermis. Our results contrast with 
previous findings such as a negative correlation between 
disease duration and the pons area in MJD/SCA3 pa-
tients9. Nevertheless, one study failed to demonstrate a 
progression of midbrain and pontine tegmentum atrophy 
by aging or disease duration19. This study also corrobo-
rate with another one that describe a differential vulner-
ability in pontine structures: pontine tegmentum atrophy 
begins from the early stage of the disease and pontine 
base progressed negatively in correlation with disease 
duration9. In a more recent study, however, volumetry 
correlated (p<0.10) with total brainstem, midbrain and 
putamen20, showing a diversity of findings in disease du-
ration and atrophy in MJD/SCA3. 
CAG number 
We identified correlation among V1, midbrain and 
total vermis, with the number of CAG expansion. One 
study failed to demonstrate a correlation between CAG 
and brainstem or cerebellar volume13. They have sug-
gested that the mutation per se, was responsible for at-
rophy and not the CAG number. One study showed a 
weak correlation between CAG number and midbrain, 
total brainstem, caudate nucleus and putamen20. Based 
on previous studies21-23 some authors, showed correla-
tion between CAG and volume of tegmentum of pons 
divided by age9. We weren’t able to find such correlation. 
Age 
Age and sex are the significant variables in volume 
measurement. Age had separate inverse correlation with 
all cerebellar structures and each of those of cerebellum, 
the cerebellar vermis being the most affected. According 
to some authors, brain stem structures remain unal-
tered regardless of disease duration21. Dorsum-medial 
areas (declive, folim and tuber-V2) and posterior lobe 
(pyramid, tonsil and nodule-V3) showed shrinking with 
age18. It has been suggested that more recent phyloge-
netic areas, with several cortical extensions, are also sus-
ceptible to the aging effect22. To diminish bias, patients 
Table 2. Correlations between volume structures and several 
parameters related to disease.
Parameter Structure Sperman p value 
Disease duration L hemisphere –0.7 0.04
Total cerebellum –0.7 0.04
V2 –0.69 0.005
R hemisphere –0.56 0.02
Mesencephalon –0.52 0.044
CAG number Total Vermis –0.7 0.04
V1 –0.69 0.004
Mesencephalon –0.53 0.042
Age Total vermis –0.78 0.01
L hemisphere –0.73 0.002
R hemisphere –0.71 0.003
Total cerebellum –0.71 0.03
V1 –0.68 0.004
V3 –0.68 0.05
V2 –0.58 0.022
ICARS Pons –0.68 0.01
L hemisphere –0.63 0.02
Total brain stem –0.62 0.01
Total cerebellum –0.6 0.02
R hemisphere –0.49 0.03
V2 –0.52 0.05
Disease duration 0.53 0.04
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and controls were paired for age and sex. Structure vol-
umes of controls didn’t correlate with age. Such find-
ings suggest that the neurodegenerative process in MJD/
SCA3 is also influenced by the patient age8.
ICARS
There was positive correlation between disease du-
ration and ICARS, suggesting the progressive char-
acter of the disease. Pons, V2, total brain stem, hemi-
spheres and total cerebellum correlated with ICARS. 
ICARS seems to be a valuable clinical parameter since 
it has been demonstrated a relevant inverse correla-
tion between this scale and cerebellar atrophy24. An in-
verse correlation was found between ICARS and spinal 
cord area in MJD/SCA3 patients although with no sta-
tistical significance25. A previous study showed correla-
tion among brainstem and cerebellar volumes and a clin-
ical scale in SCA1 patients26. They also demonstrated a 
correlation between the volume of cerebellum and the 
duration of the disease in SCA1 and SCA2 patients. A 
more recent published study showed an inverse correla-
tion between another clinical scale (Scale for the Assess-
ment and Rating of Ataxia, SARA) and total brainstem 
and all substructures, caudate nucleus, total cerebellum 
and hemispheres. To our knowledge, there are only a 
few studies concerning volume measurements in SCAs 
and clinical data (specially with ICARS), while none have 
been conducted on MJD. 
However, another study failed to demonstrate a cor-
relation between pons volume and severity of illness and 
time of disease in SCA7 patients14. Conversely, they dem-
onstrated a cerebellar correlation with both disease du-
ration and severity of illness in SCA7 patients. 
V2, hemispheres and total cerebellum volume also 
correlated with three variables: disease duration, disease 
severity (ICARS) and age. These correlations have never 
previously been demonstrated, and suggest these vari-
ables might play an important role in the disease process. 
In conclusion, the most affected structure in this 
group of MJD/SCA3 patients was the pons, followed by 
cerebellar vermis and cerebellar hemispheres. Vermis 
and total cerebellum were the most sensitive structure 
related to age while brain stem and pons strongly cor-
related with disease severity (ICARS). Cerebellum and 
brain stem atrophy volumes measurement could be 
useful as a index in detecting neuronal vulnerability pat-
terns in this disease, what may be useful in to indentify 
the progression of the disease and also as a parameter to 
be considered in future trials in MJD/SCA3.
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